Protein profile in breast cancer patients undergoing doxorubicin treatment : an iTRAQ-coupled LC-MS/MS approach
Chemotherapy is a common treatment for breast cancer and Doxorubicin is a common chemotherapeutic drug used for this purpose. However drug resistance is a great limitation to the effectiveness of chemotherapy treatment. It has been discovered that patients with single nucleotide polymorphism (SNP) i...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/16544 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Nanyang Technological University |
| 語言: | English |